RAS pathway mutation is an added-value biomarker in pediatric Philadelphia-negative B-cell acute lymphoblastic leukemia with IKZF1 deletions.
Huang YJ, Liu HC, Jaing TH, Wu KH, Wang SC, Yen HJ, Hsiao CC, Chen SH, Lin PC, Yeh TC, Sheen JM, Chen YC, Chang TK, Huang FL, Chao YH, Hou JY, Yang CP, Lin TH, Shih LY.
Huang YJ, et al. Among authors: wang sc.
Pediatr Blood Cancer. 2021 Apr;68(4):e28899. doi: 10.1002/pbc.28899. Epub 2021 Feb 1.
Pediatr Blood Cancer. 2021.
PMID: 33522704